Real-time assessment of encapsulated neonatal porcine islets prior to clinical xenotransplantation

Jennifer P. Kitzmann, Lee Law, Avik Shome, Marija Muzina, Robert B. Elliott, Kate R. Mueller, Henk Jan Schuurman, Klearchos K Papas

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Background: Porcine islet transplantation is emerging as an attractive option for the treatment of patients with type 1 diabetes, with the possibility of providing islets of higher and more consistent quality and in larger volumes than available from human pancreata. The use of encapsulated neonatal porcine islets (ENPI) is appealing because it can address islet supply limitations while reducing the need for anti-rejection therapy. Pre-transplant characterization of ENPI viability and potency is an essential component of the production process. We applied the validated assay for oxygen consumption rate normalized for DNA content (OCR/DNA) to characterize ENPI viability. Methods: ENPI of low viscosity and high m alginate were prepared according to standard methods and characterized at various culture time points up to 5 weeks. Results: The OCR/DNA (nmol/min·mgDNA ± SEM) of ENPI (235 ± 10, n = 9) was comparable to that of free NPI (255 ± 14, n = 13). After encapsulation, NPI OCR/DNA was sustained over a culture period of up to 5 weeks. The average OCR/DNA of ENPI cultured longer than 9 days was higher than that of freshly encapsulated NPI. Conclusion: This is the first characterization of ENPI by a validated and more sensitive method for product viability. The NPI encapsulation process does not compromise viability as measured by OCR/DNA, and ENPI can be cultured for up to 5 weeks with maintenance of viability. ENPI meet or exceed current adult porcine islet product release criteria (established at the University of Minnesota) for preclinical xenotransplantation in terms of OCR/DNA.

Original languageEnglish (US)
Pages (from-to)333-336
Number of pages4
JournalXenotransplantation
Volume19
Issue number6
DOIs
StatePublished - Nov 2012
Externally publishedYes

Fingerprint

Heterologous Transplantation
Swine
Oxygen Consumption
DNA
Islets of Langerhans Transplantation
Type 1 Diabetes Mellitus
Viscosity
Immunosuppression
Pancreas
Maintenance

Keywords

  • functional assessment
  • islets
  • neonatal
  • oxygen consumption rate
  • porcine

ASJC Scopus subject areas

  • Transplantation
  • Immunology

Cite this

Real-time assessment of encapsulated neonatal porcine islets prior to clinical xenotransplantation. / Kitzmann, Jennifer P.; Law, Lee; Shome, Avik; Muzina, Marija; Elliott, Robert B.; Mueller, Kate R.; Schuurman, Henk Jan; Papas, Klearchos K.

In: Xenotransplantation, Vol. 19, No. 6, 11.2012, p. 333-336.

Research output: Contribution to journalArticle

Kitzmann, JP, Law, L, Shome, A, Muzina, M, Elliott, RB, Mueller, KR, Schuurman, HJ & Papas, KK 2012, 'Real-time assessment of encapsulated neonatal porcine islets prior to clinical xenotransplantation', Xenotransplantation, vol. 19, no. 6, pp. 333-336. https://doi.org/10.1111/xen.12005
Kitzmann, Jennifer P. ; Law, Lee ; Shome, Avik ; Muzina, Marija ; Elliott, Robert B. ; Mueller, Kate R. ; Schuurman, Henk Jan ; Papas, Klearchos K. / Real-time assessment of encapsulated neonatal porcine islets prior to clinical xenotransplantation. In: Xenotransplantation. 2012 ; Vol. 19, No. 6. pp. 333-336.
@article{1fd3c8bb29b94ea2a90b2417e0030e90,
title = "Real-time assessment of encapsulated neonatal porcine islets prior to clinical xenotransplantation",
abstract = "Background: Porcine islet transplantation is emerging as an attractive option for the treatment of patients with type 1 diabetes, with the possibility of providing islets of higher and more consistent quality and in larger volumes than available from human pancreata. The use of encapsulated neonatal porcine islets (ENPI) is appealing because it can address islet supply limitations while reducing the need for anti-rejection therapy. Pre-transplant characterization of ENPI viability and potency is an essential component of the production process. We applied the validated assay for oxygen consumption rate normalized for DNA content (OCR/DNA) to characterize ENPI viability. Methods: ENPI of low viscosity and high m alginate were prepared according to standard methods and characterized at various culture time points up to 5 weeks. Results: The OCR/DNA (nmol/min·mgDNA ± SEM) of ENPI (235 ± 10, n = 9) was comparable to that of free NPI (255 ± 14, n = 13). After encapsulation, NPI OCR/DNA was sustained over a culture period of up to 5 weeks. The average OCR/DNA of ENPI cultured longer than 9 days was higher than that of freshly encapsulated NPI. Conclusion: This is the first characterization of ENPI by a validated and more sensitive method for product viability. The NPI encapsulation process does not compromise viability as measured by OCR/DNA, and ENPI can be cultured for up to 5 weeks with maintenance of viability. ENPI meet or exceed current adult porcine islet product release criteria (established at the University of Minnesota) for preclinical xenotransplantation in terms of OCR/DNA.",
keywords = "functional assessment, islets, neonatal, oxygen consumption rate, porcine",
author = "Kitzmann, {Jennifer P.} and Lee Law and Avik Shome and Marija Muzina and Elliott, {Robert B.} and Mueller, {Kate R.} and Schuurman, {Henk Jan} and Papas, {Klearchos K}",
year = "2012",
month = "11",
doi = "10.1111/xen.12005",
language = "English (US)",
volume = "19",
pages = "333--336",
journal = "Xenotransplantation",
issn = "0908-665X",
publisher = "Wiley-Blackwell",
number = "6",

}

TY - JOUR

T1 - Real-time assessment of encapsulated neonatal porcine islets prior to clinical xenotransplantation

AU - Kitzmann, Jennifer P.

AU - Law, Lee

AU - Shome, Avik

AU - Muzina, Marija

AU - Elliott, Robert B.

AU - Mueller, Kate R.

AU - Schuurman, Henk Jan

AU - Papas, Klearchos K

PY - 2012/11

Y1 - 2012/11

N2 - Background: Porcine islet transplantation is emerging as an attractive option for the treatment of patients with type 1 diabetes, with the possibility of providing islets of higher and more consistent quality and in larger volumes than available from human pancreata. The use of encapsulated neonatal porcine islets (ENPI) is appealing because it can address islet supply limitations while reducing the need for anti-rejection therapy. Pre-transplant characterization of ENPI viability and potency is an essential component of the production process. We applied the validated assay for oxygen consumption rate normalized for DNA content (OCR/DNA) to characterize ENPI viability. Methods: ENPI of low viscosity and high m alginate were prepared according to standard methods and characterized at various culture time points up to 5 weeks. Results: The OCR/DNA (nmol/min·mgDNA ± SEM) of ENPI (235 ± 10, n = 9) was comparable to that of free NPI (255 ± 14, n = 13). After encapsulation, NPI OCR/DNA was sustained over a culture period of up to 5 weeks. The average OCR/DNA of ENPI cultured longer than 9 days was higher than that of freshly encapsulated NPI. Conclusion: This is the first characterization of ENPI by a validated and more sensitive method for product viability. The NPI encapsulation process does not compromise viability as measured by OCR/DNA, and ENPI can be cultured for up to 5 weeks with maintenance of viability. ENPI meet or exceed current adult porcine islet product release criteria (established at the University of Minnesota) for preclinical xenotransplantation in terms of OCR/DNA.

AB - Background: Porcine islet transplantation is emerging as an attractive option for the treatment of patients with type 1 diabetes, with the possibility of providing islets of higher and more consistent quality and in larger volumes than available from human pancreata. The use of encapsulated neonatal porcine islets (ENPI) is appealing because it can address islet supply limitations while reducing the need for anti-rejection therapy. Pre-transplant characterization of ENPI viability and potency is an essential component of the production process. We applied the validated assay for oxygen consumption rate normalized for DNA content (OCR/DNA) to characterize ENPI viability. Methods: ENPI of low viscosity and high m alginate were prepared according to standard methods and characterized at various culture time points up to 5 weeks. Results: The OCR/DNA (nmol/min·mgDNA ± SEM) of ENPI (235 ± 10, n = 9) was comparable to that of free NPI (255 ± 14, n = 13). After encapsulation, NPI OCR/DNA was sustained over a culture period of up to 5 weeks. The average OCR/DNA of ENPI cultured longer than 9 days was higher than that of freshly encapsulated NPI. Conclusion: This is the first characterization of ENPI by a validated and more sensitive method for product viability. The NPI encapsulation process does not compromise viability as measured by OCR/DNA, and ENPI can be cultured for up to 5 weeks with maintenance of viability. ENPI meet or exceed current adult porcine islet product release criteria (established at the University of Minnesota) for preclinical xenotransplantation in terms of OCR/DNA.

KW - functional assessment

KW - islets

KW - neonatal

KW - oxygen consumption rate

KW - porcine

UR - http://www.scopus.com/inward/record.url?scp=84870527380&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84870527380&partnerID=8YFLogxK

U2 - 10.1111/xen.12005

DO - 10.1111/xen.12005

M3 - Article

C2 - 23088180

AN - SCOPUS:84870527380

VL - 19

SP - 333

EP - 336

JO - Xenotransplantation

JF - Xenotransplantation

SN - 0908-665X

IS - 6

ER -